Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2.

Authors: Hussain, Shehnaz K; Madeleine, Margaret M; Johnson, Lisa G; Du, Qin; Malkki, Mari; Wilkerson, Hui-Wen; Farin, Federico M; Carter, Joseph J; Galloway, Denise A; Daling, Janet R; Petersdorf, Effie W; Schwartz, Stephen M

Published In Cancer Epidemiol Biomarkers Prev, (2008 Jul)

Abstract: Cigarette smoking is an established cofactor to human papillomavirus (HPV) in the development of cervical and vulvar squamous cell carcinoma (SCC), and may influence risk through an immunosuppressive pathway. Genetic variation in interleukin 2 (IL2), associated in some studies with the inhibition of HPV-targeted immunity, may modify the effect of smoking on the risk of HPV-related anogenital cancers. We conducted a population-based case-only study to measure the departure from a multiplicative joint effect of cigarette smoking and IL2 variation on cervical and vulvar SCC. Genotyping of the four IL2 tagSNPs (rs2069762, rs2069763, rs2069777, and rs2069778) was done in 399 cervical and 486 vulvar SCC cases who had been interviewed regarding their smoking history. Compared with cases carrying the rs2069762 TT genotype, we observed significant departures from multiplicativity for smoking and carriership of the TG or GG genotypes in vulvar SCC risk [interaction odds ratio (IOR), 1.67; 95% confidence interval (CI), 1.16-2.41]. Carriership of one of three diplotypes, together with cigarette smoking, was associated with either a supramultiplicative (TGCT/GGCC; IOR, 2.09; 95% CI, 0.98-4.46) or submultiplicative (TTCC/TGTC; IOR, 0.37; 95% CI, 0.16-0.85 or TGCT/TGCC; IOR, 0.37; 95% CI, 0.15-0.87) joint effect in vulvar cancer risk. For cervical SCC, departure from multiplicativity was observed for smokers homozygous for the rs2069763 variant allele (TT versus GG or GT genotypes; IOR, 1.87; 95% CI, 1.00-3.48), and for carriership of the TTCC/TTCC diplotype (IOR, 2.08; 95% CI, 1.01-4.30). These results suggest that cervical and vulvar SCC risk among cigarette smokers is modified by genetic variation in IL2.

PubMed ID: 18628433 Exiting the NIEHS site

MeSH Terms: Adolescent; Adult; Aged; Alleles; Biomarkers, Tumor/blood; Biomarkers, Tumor/genetics; DNA, Neoplasm/genetics*; Female; Genetic Predisposition to Disease; Genetic Variation*; Genotype; Humans; Incidence; Interleukin-2/blood; Interleukin-2/genetics*; Middle Aged; Polymerase Chain Reaction; Prognosis; Retrospective Studies; Smoking/adverse effects*; Smoking/blood; Smoking/epidemiology; Uterine Cervical Neoplasms/blood; Uterine Cervical Neoplasms/epidemiology*; Uterine Cervical Neoplasms/etiology; Vulvar Neoplasms/blood; Vulvar Neoplasms/epidemiology*; Vulvar Neoplasms/etiology; Washington/epidemiology; Young Adult

Back
to Top